Watch VTAK. Know when insiders buy.
One email the day a filing lands. Free.
VTAK
Catheter Precision, Inc.
0.15
+0.00 +0.00%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.2MP/E —DIV YIELD —FCF YIELD -434.18%REV TTM $1.9M +219.2%NET INCOME −$13MNET DEBT $2.4M52W 0.14 – 3.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1M | +380.7% | 9.6% | −$4M | −$3.3M | — | -0.92 | −$2.9M | $15K | −$2.9M | Aug 14 |
| Q1 2026 · Mar 31 | $432K | +202.1% | 90.3% | −$2.3M | −$1.7M | — | -1.39 | −$2.8M | $6K | −$2.8M | May 18 |
| Q4 2025 · Dec 31derived | $238K | +59.7% | 91.6% | −$9.9M | −$5.8M | — | -2.88 | −$1.5M | $0 | −$1.5M | Mar 31 |
| Q3 2025 · Sep 30 | $226K | +135.4% | 92.0% | −$3M | −$2.3M | — | -1.70 | −$2.2M | $0 | −$2.2M | Nov 13 |
| Q2 2025 · Jun 30 | $212K | +128.0% | 93.4% | −$4.7M | −$5.1M | — | -7.28 | −$2.3M | $7K | −$2.3M | Aug 14 |
| Q1 2025 · Mar 31 | $143K | +74.4% | 92.3% | −$3.6M | −$4M | — | -6.81 | −$2.3M | $10K | −$2.3M | May 18 |
| Q4 2024 · Dec 31derived | $149K | +16.4% | 92.6% | −$3.1M | −$5.6M | — | 49.36 | −$2.9M | $0 | −$2.9M | Mar 31 |
| Q3 2024 · Sep 30 | $96K | −27.8% | 89.6% | −$2.9M | −$4.1M | — | -38.17 | −$2.8M | $0 | −$2.8M | Nov 13 |
| Q2 2024 · Jun 30 | $93K | — | 82.8% | −$2.7M | −$4.2M | — | -5.57 | −$1.7M | $45K | −$1.7M | Aug 11 |
| Q1 2024 · Mar 31 | $82K | — | 93.9% | −$2.6M | −$2.7M | — | -3.60 | −$1.9M | $22K | −$2M | May 14 |
| Q4 2023 · Dec 31derived | $128K | — | 94.5% | −$2.6M | −$669K | — | — | −$1.9M | $18K | −$1.9M | Mar 31 |
| Q3 2023 · Sep 30 | $133K | — | 95.5% | −$2.7M | −$1.9M | — | — | −$1.8M | $1K | −$1.8M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $819K | 92.3% | −$21.1M | −$17.2M | -2098.0% | -15.90 | −$8.3M | $17K | −$8.3M | — | — |
| FY2024 · to Dec 31 | $420K | 90.0% | −$11.2M | −$16.6M | -3962.6% | -126.91 | −$9.3M | $67K | −$9.3M | — | — |
| FY2023 · to Dec 31 | $442K | 93.2% | −$78.1M | −$70.6M | -15966.5% | -129.88 | −$20.6M | $76K | −$20.7M | — | — |
| FY2022 · to Dec 31 | $14K | -1050.0% | −$27M | −$26.9M | -191892.9% | -25.98 | −$22.6M | $17K | −$22.6M | — | — |
| FY2021 · to Dec 31 | $22K | -6990.9% | −$29.3M | −$25.1M | -113954.5% | -248.22 | −$27.6M | $265K | −$27.9M | — | — |
| FY2020 · to Dec 31 | $4.4M | -43.4% | −$35.4M | −$36M | -818.3% | -21.22 | −$28.3M | $67K | −$28.4M | — | — |
Every number comes from Catheter Precision, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.